673 related articles for article (PubMed ID: 28230459)
1. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes Associated With a Collaborative Pharmacist-Endocrinologist Diabetes Intense Medical Management "Tune Up" Clinic in Complex Patients.
Morello CM; Christopher ML; Ortega L; Khoan J; Rotunno T; Edelman SV; Henry RR; Hirsch JD
Ann Pharmacother; 2016 Jan; 50(1):8-16. PubMed ID: 26546580
[TBL] [Abstract][Full Text] [Related]
3. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
Morello CM; Rotunno T; Khoan J; Hirsch JD
Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
[TBL] [Abstract][Full Text] [Related]
4. Development of a Pharmacoeconomic Model to Demonstrate the Effect of Clinical Pharmacist Involvement in Diabetes Management.
Ourth H; Nelson J; Spoutz P; Morreale AP
J Manag Care Spec Pharm; 2018 May; 24(5):449-457. PubMed ID: 29694293
[TBL] [Abstract][Full Text] [Related]
5. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
Yu J; Shah BM; Ip EJ; Chan J
J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
[TBL] [Abstract][Full Text] [Related]
6. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
Morello CM; Nguyen T; Tao L; Hirsch JD
Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551
[No Abstract] [Full Text] [Related]
7. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
[TBL] [Abstract][Full Text] [Related]
8. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
[TBL] [Abstract][Full Text] [Related]
10. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
de Oliveira DR; Brummel AR; Miller DB
J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.
Tate ML; Hopper S; Bergeron SP
J Manag Care Spec Pharm; 2018 Feb; 24(2):160-164. PubMed ID: 29384022
[TBL] [Abstract][Full Text] [Related]
12. Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
Hoover ND; Turner RB; Sampson J; Pye T; Hotan T
J Manag Care Spec Pharm; 2020 Jan; 26(1):30-34. PubMed ID: 31880232
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomic analysis of the diabetes initiative program: a pharmacist-physician collaborative care model.
Franklin BE; Farland MZ; Thomas J; McFarland MS; Ray SM; Byrd DC
Ann Pharmacother; 2013 Dec; 47(12):1627-34. PubMed ID: 24259610
[TBL] [Abstract][Full Text] [Related]
14. Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes.
Sherrill CH; Houpt CT; Dixon EM; Richter SJ
J Manag Care Spec Pharm; 2020 May; 26(5):600-609. PubMed ID: 32347180
[TBL] [Abstract][Full Text] [Related]
15. The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.
McAdam-Marx C; Dahal A; Jennings B; Singhal M; Gunning K
J Manag Care Spec Pharm; 2015 Jun; 21(6):452-68. PubMed ID: 26011547
[TBL] [Abstract][Full Text] [Related]
16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Effects on Metabolic Biomarkers in Veterans 12 Months Following Discharge from Pharmacist-Provided Diabetes Care: A Retrospective Cohort Study.
Morello CM; Lai L; Chen C; Leung CM; Hirsch JD; Bounthavong M
Pharmacy (Basel); 2022 Jun; 10(3):. PubMed ID: 35736778
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.
Pousinho S; Morgado M; Falcão A; Alves G
J Manag Care Spec Pharm; 2016 May; 22(5):493-515. PubMed ID: 27123912
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
[TBL] [Abstract][Full Text] [Related]
20. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
Korcegez EI; Sancar M; Demirkan K
J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
